FDA approves Roche’s Actemra/RoActemra (tocilizumab) for the treatment of CAR T cell-induced cytokine release syndrome

Basel, 30 August 2017 FDA approves Roche’s Actemra/RoActemra (tocilizumab) for the treatment of CAR T cell-induced cytokine release syndrome Actemra/RoActemra is the first FDA-approved treatment for severe or life-threatening cytokine release syndrome induced by CAR T cell therapy CAR T cell therapy is an immunotherapy designed for the treatment of certain cancers This is the... Read more

FDA approves Roche’s Actemra/RoActemra (tocilizumab) for the treatment of CAR T cell-induced cytokine release syndrome

Basel, 30 August 2017 FDA approves Roche’s Actemra/RoActemra (tocilizumab) for the treatment of CAR T cell-induced cytokine release syndrome Actemra/RoActemra is the first FDA-approved treatment for severe or life-threatening cytokine release syndrome induced by CAR T cell therapy CAR T cell therapy is an immunotherapy designed for the treatment of certain cancers This is the... Read more

Shimadzu's New EDX-8100 Energy Dispersive X-Ray Fluorescence Spectrometer Enables Analysis of Liquid Samples with High Sensitivity by Helium Purging

Energy dispersive X-ray fluorescence (ED-XRF) spectrometers can analyze the composition and concentration of elements contained in samples by detecting fluorescence X-rays generated from the surface of samples irradiated with X-rays. They can be used to easily and non-destructively analyze samples in a wide range of forms, including solids and powders. The EDX-7000 and EDX-8000 energy... Read more

Leica FL560 achieves First FDA Clearance for cerebrovascular fluorescence with fluorescein

View of an Arteriovenous Malformation (AVM) viewed with FL560 fluorescence. Photo courtesy of Cleopatra Charalampaki, MD, PhD, Professor of Neurosurgery, Department of Neurosurgery, Cologne Medical Center, Germany Leica Microsystems is proud to be the first company to attain FDA 510(k) clearance for its FL560 fluorescence microscope filter for visualization of cerebrovascular blood flow in conjunction... Read more

FDA grants Priority Review for Roche’s Gazyva in previously untreated follicular lymphoma

Basel, 28 August 2017 FDA grants Priority Review for Roche’s Gazyva in previously untreated follicular lymphoma Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has accepted the company’s supplemental Biologics License Application (sBLA) and granted Priority Review for Gazyva® (obinutuzumab) in combination with chemotherapy followed by Gazyva... Read more

Free Webinar On-Demand: Basics in Component Cleanliness Analysis

For automotive manufacturers and auto parts suppliers, obtaining component cleanliness results rapidly, accurately, and reproducibly over the entire workflow is a significant advantage. Making it easier to build up facilities, knowledge and expertise in component cleanliness Pall and Leica can offer unique workflow solutions fitting to individual needs and compliant with common standards. Often for... Read more

Free Webinar On-Demand: Rate the quality of your steel

The quality of steel is an essential topic in automotive, metalworking and building industries. To ensure the highest standards, an accurate and reliable Quality Assurance workflow for the inspection of non-metallic inclusions is crucial. Leica Microsystems offers state-of-the-art and individualized microscopy solutions, allowing you to inspect the microstructure and evaluate the non-metallic inclusion content of... Read more